Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.2000
+0.0010 (0.50%)
At close: Nov 27, 2025

Biomark Diagnostics Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Nov '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
231417101121
Upgrade
Market Cap Growth
97.46%-15.29%61.96%-7.18%-45.46%140.92%
Upgrade
Enterprise Value
231518121221
Upgrade
Last Close Price
0.220.140.190.130.140.27
Upgrade
PS Ratio
308.93145.04152.12100.50356.91-
Upgrade
PB Ratio
44.1612.85-40.73-13.42-24.67-386.98
Upgrade
P/TBV Ratio
44.1612.85----
Upgrade
EV/Sales Ratio
-154.52161.35110.73393.16-
Upgrade
Debt / Equity Ratio
0.930.64-2.54-1.44-3.09-12.70
Upgrade
Asset Turnover
0.090.070.180.140.04-
Upgrade
Quick Ratio
1.732.140.160.060.310.98
Upgrade
Current Ratio
1.732.140.160.080.331.00
Upgrade
Return on Equity (ROE)
--340.70%----
Upgrade
Return on Assets (ROA)
-79.14%-60.59%-117.29%-104.38%-66.20%-80.77%
Upgrade
Return on Capital (ROIC)
-103.04%-67.44%-148.56%-125.52%-71.12%-259.30%
Upgrade
Return on Capital Employed (ROCE)
-197.50%-107.60%1099.30%197.40%4328.70%-3366.60%
Upgrade
Earnings Yield
-4.34%-8.62%-5.75%-11.94%-9.27%-3.57%
Upgrade
FCF Yield
-3.73%-4.90%-3.98%-5.96%-8.06%-2.64%
Upgrade
Buyback Yield / Dilution
-10.10%-6.67%-2.97%-6.22%-6.31%-2.82%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.